NYSE · Medical - Instruments & Supplies

HAE (HAE) Stock

$83.60 -2.08% NYSE: HAE Healthcare

Valuation

MetricValue
Price$83.60
Market Cap$3.80B
P/E Ratio37.62
P/B Ratio4.38
P/S Ratio2.63
EPS (TTM)$3.31
52-Week High$87.32
52-Week Low$47.32
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE12.03%
ROA6.49%
ROCE30.28%
Gross Margin57.34%
Operating Margin18.15%
Net Margin7.29%
Debt/Equity1.54
Current Ratio2.95

Annual Financials (USD)

Metric20222023202420252026
Revenue$993.0M$1.2B$1.3B$1.4B$1.3B
Operating Profit$81.0M$156.0M$165.0M$222.0M$241.0M
Net Profit$43.0M$115.0M$118.0M$168.0M$97.0M
EPS$0.84$2.24$2.29$3.31$2.05
Op Margin8.1%13.3%12.6%16.3%18.1%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$1.9B$1.9B$2.2B$2.5B$2.4B
Total Liabilities$1.1B$1.1B$1.2B$1.6B$1.6B
Cash$259.0M$284.0M$179.0M$307.0M$245.0M
Borrowings$781.0M$766.0M$808.0M$1.2B$1.2B

Latest News

1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm StockStory · Jul 15, 2026 HAE: Lowering target price to $78.00 Argus Research · Jul 15, 2026 Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026 PR Newswire · Jul 8, 2026 Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now? Zacks · Jul 3, 2026 3 Reasons HAE is Risky and 1 Stock to Buy Instead StockStory · Jun 30, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$172.0M$273.0M$182.0M$182.0M$293.0M
Investing Cash Flow$-183.0M$-254.0M$-389.0M$-201.0M$-212.0M
Financing Cash Flow$2.0M$-91.0M$-7.0M$-338.0M$-180.0M
Net Cash Flow$67.0M$25.0M$-106.0M$128.0M$-61.0M
Free Cash Flow$76.0M$163.0M$115.0M$142.0M$260.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.25
EV / EBITDA12.83
FCF Yield7.43%
Quick Ratio1.87
Interest Coverage8.31
Return 1Y4.64%
Return 3Y-16.00%
Return 5Y31.48%

Ownership

Insiders Held1.22%
Institutions Held109.55%
Institutions Float Held110.90%
Institutional HolderSharesReport Date
Blackrock Inc.5,619,9792026-03-31
Neuberger Berman Group, LLC3,560,9182026-03-31
AQR Capital Management, LLC3,356,5432026-03-31
Vanguard Portfolio Management LLC2,559,3162026-03-31
Vanguard Capital Management LLC2,090,3892026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BEAM $25.62 +2.19% -35.36 $2.64B 0.00%
BHCBausch Health Companies Inc. $4.58 +3.27% -1.38 $1.71B 0.00%
CON $30.76 -1.16% 19.32 $3.94B 0.99%
CPRX $31.49 +0.00% 18.00 $3.85B 0.00%
ITGR $100.38 +0.99% 31.13 $3.41B 0.00%

About HAE

HAE stock trades at $83.60 with a market capitalization of $3.80B. The stock is valued at a price-to-earnings (P/E) ratio of 37.62, price-to-book of 4.38, price-to-sales of 2.63. Over the past 52 weeks the stock has ranged between $47.32 and $87.32, and currently trades 4.3% below its 52-week high.

On profitability, HAE generates a return on equity (ROE) of 12.03%, above the typical market average, return on capital employed of 30.28%, an operating margin of 18.15%, a net profit margin of 7.29%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides